RT Journal Article
SR Electronic
T1 Mathematical Modeling and Optimal Control Analysis of COVID-19 in Ethiopia
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.07.23.20160473
DO 10.1101/2020.07.23.20160473
A1 Alemneh, Haileyesus Tessema
A1 Tilahun, Getachew Teshome
YR 2020
UL http://medrxiv.org/content/early/2020/07/24/2020.07.23.20160473.abstract
AB In this paper we developed a deterministic mathematical model of the pandemic COVID-19 transmission in Ethiopia, which allows transmission by exposed humans. We proposed an SEIR model using system of ordinary differential equations. First the major qualitative analysis, like the disease free equilibruim point, endemic equilibruim point, basic reproduction number, stability analysis of equilibrium points and sensitivity analysis was rigorously analysed. Second, we introduced time dependent controls to the basic model and extended to an optimal control model of the disease. We then analysed using Pontryagin’s Maximum Principle to derive necessary conditions for the optimal control of the pandemic. The numerical simulation indicated that, an integrated strategy effective in controling the epidemic and the gvernment must apply all control strategies in combating COVID-19 at short period of time.Competing Interest StatementThe authors have declared no competing interest.Clinical Protocols http://www.hailegech.com Funding StatementNot ApplicableAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Haileyesus Tessema AlemnehAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data relevant to this publication will be provided when needed.